CN103082286A - 增强免疫力的保健食品及其制作方法 - Google Patents
增强免疫力的保健食品及其制作方法 Download PDFInfo
- Publication number
- CN103082286A CN103082286A CN2013100019677A CN201310001967A CN103082286A CN 103082286 A CN103082286 A CN 103082286A CN 2013100019677 A CN2013100019677 A CN 2013100019677A CN 201310001967 A CN201310001967 A CN 201310001967A CN 103082286 A CN103082286 A CN 103082286A
- Authority
- CN
- China
- Prior art keywords
- immunity
- sterculia seed
- preparation
- add
- momordica grosvenori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036039 immunity Effects 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 16
- 235000013305 food Nutrition 0.000 title abstract description 6
- 235000013717 Houttuynia Nutrition 0.000 claims abstract description 30
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 42
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 42
- 241000934878 Sterculia Species 0.000 claims description 40
- 235000021282 Sterculia Nutrition 0.000 claims description 40
- 229940059107 sterculia Drugs 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 31
- 241000758769 Houttuynia Species 0.000 claims description 29
- 239000000284 extract Substances 0.000 claims description 28
- 235000013402 health food Nutrition 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000007937 lozenge Substances 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 235000013361 beverage Nutrition 0.000 claims description 18
- 229930006000 Sucrose Natural products 0.000 claims description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 239000003826 tablet Substances 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 7
- 238000013467 fragmentation Methods 0.000 claims description 6
- 238000006062 fragmentation reaction Methods 0.000 claims description 6
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 4
- 241001038563 Pseudostellaria Species 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000005538 encapsulation Methods 0.000 claims description 4
- 239000007888 film coating Substances 0.000 claims description 4
- 238000009501 film coating Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000011812 mixed powder Substances 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000005550 wet granulation Methods 0.000 claims description 4
- 235000020985 whole grains Nutrition 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 19
- 230000006870 function Effects 0.000 abstract description 15
- 230000000242 pagocytic effect Effects 0.000 abstract description 9
- 210000004072 lung Anatomy 0.000 abstract description 8
- 210000002540 macrophage Anatomy 0.000 abstract description 8
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 5
- 201000007100 Pharyngitis Diseases 0.000 abstract description 5
- 230000007969 cellular immunity Effects 0.000 abstract description 3
- 230000004727 humoral immunity Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000009815 Momordica Nutrition 0.000 abstract 1
- 241000218984 Momordica Species 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 32
- 210000000952 spleen Anatomy 0.000 description 13
- 239000003814 drug Substances 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000003304 gavage Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 239000013642 negative control Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000034994 death Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 206010061598 Immunodeficiency Diseases 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 208000033065 inborn errors of immunity Diseases 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010013183 Dislocation of vertebra Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 208000031404 Chromosome Aberrations Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- -1 Sijunzi Tang Substances 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 231100000005 chromosome aberration Toxicity 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008862 fructus schizandrae, radix ginseng, radix ophiopogonis drug combination Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021179 potluck Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310001967.7A CN103082286B (zh) | 2013-01-05 | 2013-01-05 | 增强免疫力的保健食品及其制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310001967.7A CN103082286B (zh) | 2013-01-05 | 2013-01-05 | 增强免疫力的保健食品及其制作方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103082286A true CN103082286A (zh) | 2013-05-08 |
CN103082286B CN103082286B (zh) | 2015-01-21 |
Family
ID=48195824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310001967.7A Expired - Fee Related CN103082286B (zh) | 2013-01-05 | 2013-01-05 | 增强免疫力的保健食品及其制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103082286B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104522801A (zh) * | 2014-12-22 | 2015-04-22 | 百花医药集团股份有限公司 | 一种保健饮料及其制作方法 |
CN107455627A (zh) * | 2017-07-31 | 2017-12-12 | 贵州盛达生植物发展有限公司 | 一种铁皮石斛植物饮料及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152004A (zh) * | 2006-09-27 | 2008-04-02 | 上海水产大学 | 一种具有清热败火功效的方便型药膳包及其制作方法 |
CN101396466A (zh) * | 2008-10-18 | 2009-04-01 | 洪国隆 | 一种药食两用感冒药茶组合物及其制备方法和用途 |
CN102697941A (zh) * | 2011-03-28 | 2012-10-03 | 胡维民 | 直接洗鼻的一种预防流感的中成药 |
CN102743688A (zh) * | 2012-06-07 | 2012-10-24 | 王晓兵 | 一种抗病毒治疗发热的中药口服液 |
-
2013
- 2013-01-05 CN CN201310001967.7A patent/CN103082286B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152004A (zh) * | 2006-09-27 | 2008-04-02 | 上海水产大学 | 一种具有清热败火功效的方便型药膳包及其制作方法 |
CN101396466A (zh) * | 2008-10-18 | 2009-04-01 | 洪国隆 | 一种药食两用感冒药茶组合物及其制备方法和用途 |
CN102697941A (zh) * | 2011-03-28 | 2012-10-03 | 胡维民 | 直接洗鼻的一种预防流感的中成药 |
CN102743688A (zh) * | 2012-06-07 | 2012-10-24 | 王晓兵 | 一种抗病毒治疗发热的中药口服液 |
Non-Patent Citations (4)
Title |
---|
杜连起等: "《新型蔬菜及瓜类饮料加工技术》", 28 February 2006 * |
林泗定等: "太子参化学成分和生物活性研究进展太子参化学成分和生物活性研究进展", 《中国民族民间医药》 * |
熊建华: "自制饮料-胖大海泡冰糖", 《家庭医学》 * |
贺福元等: "鱼腥草及其制剂的药理与免疫毒理作用研究进展", 《中国药理学与毒理学杂志》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104522801A (zh) * | 2014-12-22 | 2015-04-22 | 百花医药集团股份有限公司 | 一种保健饮料及其制作方法 |
CN107455627A (zh) * | 2017-07-31 | 2017-12-12 | 贵州盛达生植物发展有限公司 | 一种铁皮石斛植物饮料及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103082286B (zh) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103893549B (zh) | 一种缓解疲劳的中药组合物及其制备方法和用途 | |
CN102114044A (zh) | 一种人工加工熊胆粉及其制备方法 | |
CN100358549C (zh) | 一种治疗腹泻病的中药组合物 | |
CN103585400B (zh) | 具有增强免疫功能和缓解疲劳作用的组合物及其制备方法 | |
CN102716223B (zh) | 一种治疗上呼吸道感染的中药组合物及其制备方法 | |
CN101773580B (zh) | 一种用于治疗小儿急性支气管炎的中药组合物及制备方法 | |
CN102895326B (zh) | 一种治疗小儿感冒的中药组合物及其制备方法 | |
CN103082286B (zh) | 增强免疫力的保健食品及其制作方法 | |
CN105596780A (zh) | 一种铁皮石斛保健酒及其制备方法 | |
CN101181561B (zh) | 一种中药组合物及其制备方法和应用 | |
CN100431548C (zh) | 一种用于治疗外感高热和急慢性肝损伤的中药成分组合物及制备方法 | |
CN107441383A (zh) | 一种用于儿童清热解表组方药物、制备方法及其应用 | |
CN104286844A (zh) | 一种提高免疫力的食品、保健品或药物组合物 | |
CN107951992A (zh) | 一种用于增强免疫力的中药组合物及其制备方法 | |
CN100435817C (zh) | 一种治疗呼吸系统疾患的中药组合物及其制备方法 | |
CN104189038B (zh) | 用于调理女性生理健康和免疫功能的中药制剂 | |
CN105815786A (zh) | 一种双花黄精片剂及其制备方法 | |
CN105343274A (zh) | 一种具有消炎止咳作用的药物组合物 | |
CN104840737A (zh) | 具有补气润肺作用的中药组合物及其制备方法和应用 | |
CN103251816A (zh) | 一种增强免疫力的制剂及其制备方法 | |
CN111053848A (zh) | 一种调理儿童积热体质的中药组合物及其制备方法 | |
CN107802726A (zh) | 一种覆盆子保健品及其制备方法 | |
CN106620351A (zh) | 一种治疗和预防流感的中药组合物及其制备方法 | |
CN104288670B (zh) | 一种治疗或/和预防阿尔茨海默病药物组合物及其制备方法和用途 | |
CN102973657A (zh) | 芩暴红止咳合剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 401520 northeast section of intersection of B road and Nansha section of Zi Lu Road, Hechuan Industrial Park, Chongqing Applicant after: CHONGQING BAIHUA BIO-PHARMACEUTICAL CO., LTD. Address before: 401520 Chongqing Hechuan South Office 1108 Century Avenue No. 3 4-2 Applicant before: Chongqing Baihua Biological Medical Co., Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: CHONGQING BAIHUA BIO-PHARMACEUTICAL CO., LTD. TO: CHONGQING BAIHUA BIOLOGICAL PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Health-care food for enhancing immunity and preparation method thereof Effective date of registration: 20160304 Granted publication date: 20150121 Pledgee: Shenzhen HongMian two equity investment partnership (limited partnership) Pledgor: CHONGQING BAIHUA BIO-PHARMACEUTICAL CO., LTD. Registration number: 2016990000167 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150121 Termination date: 20170105 |